Effect of FENHEXAMID (cas 126833-17-8) and cyprodinil on the expression of cell cycle- and metastasis-related genes via an estrogen receptor-dependent pathway in cellular and xenografted ovarian cancer models
-
Add time:07/25/2019 Source:sciencedirect.com
ABSTRACTFENHEXAMID (cas 126833-17-8) and cyprodinil are antifungal agents (pesticides) used for agriculture, and are present at measurable amounts in fruits and vegetables. In the current study, the effects of fenhexamid and cyprodinil on cancer cell proliferation and metastasis were examined. Additionally, the protein expression levels of cyclin D1 and cyclin E as well as cathepsin D were analyzed in BG-1 ovarian cancer cells that express estrogen receptors (ERs). The cells were cultured with 0.1% dimethyl sulfoxide (DMSO; control), 17β-estradiol (E2; 10− 9 M), and fenhexamid or cyprodinil (10–5–10− 7 M). Results of a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay showed that fenhexamid and cyprodinil increased BG-1 cell proliferation about 1.5 to 2 times similar to E2 (5 times) compared to the control. When the cells were co-treated with ICI 182,780 (10− 8 M), an ER antagonist, the proliferation of pesticide-treated BG-1 cells was decreased to the level of the control. A wound healing assay revealed that the pesticides reduced the disrupted area in the BG-1 cell monolayer similar to E2. Protein levels of cyclin D1 and E as well as cathepsin D were increased by fenhexamid and cyprodinil. This effect was reversed by co-treatment with ICI 182,780. In a xenograft mouse model with transplanted BG-1 cells, cyprodinil significantly increased tumor mass formation about 2 times as did E2 (6 times) compared to the vehicle (0.1% DMSO) over an 80-day period. In contrast, fenhexamid did not promote ovarian tumor formation in this mouse model. Cyprodinil also induced cell proliferation along with the expression of proliferating cell nuclear antigen (PCNA) and cathepsin D in tumor tissues similar to E2. Taken together, these results imply that fenhexamid and cyprodinil may have disruptive effects on ER-expressing cancer by altering the cell cycle- and metastasis-related gene expression via an ER-dependent pathway.
We also recommend Trading Suppliers and Manufacturers of FENHEXAMID (cas 126833-17-8). Pls Click Website Link as below: cas 126833-17-8 suppliers
Prev:A new transformant selection system for the gray mold fungus Botrytis cinerea based on the expression of FENHEXAMID (cas 126833-17-8)-insensitive ERG27 variants
Next:Pesticide interaction with environmentally important cations: A molecular dynamics and DFT study of metamitron and FENHEXAMID (cas 126833-17-8)) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Toxic responses and antioxidative enzymes activity of Scenedesmus obliquus exposed to FENHEXAMID (cas 126833-17-8) and atrazine, alone and in mixture07/30/2019
- Residual pattern of FENHEXAMID (cas 126833-17-8) on pepper fruits grown under greenhouse conditions using HPLC and confirmation via tandem mass spectrometry07/29/2019
- Impact of a pesticide cocktail (FENHEXAMID (cas 126833-17-8), folpel, deltamethrin) on the abundance of Glomeromycota in two agricultural soils07/28/2019
- Evaluation of the effect of FENHEXAMID (cas 126833-17-8) and mepanipyrim in the volatile composition of Tempranillo and Graciano wines07/27/2019
- Pesticide interaction with environmentally important cations: A molecular dynamics and DFT study of metamitron and FENHEXAMID (cas 126833-17-8)07/26/2019
- A new transformant selection system for the gray mold fungus Botrytis cinerea based on the expression of FENHEXAMID (cas 126833-17-8)-insensitive ERG27 variants07/24/2019
- Efficacy of FENHEXAMID (cas 126833-17-8) treatments against Botrytis cinerea in grapevine as affected by time of application and meteorological conditions07/23/2019
- Baseline sensitivity of Monilinia laxa from Greece to FENHEXAMID (cas 126833-17-8) and analysis of FENHEXAMID (cas 126833-17-8)-resistant mutants07/22/2019
- Elucidation of intermolecular interaction of bovine serum albumin with FENHEXAMID (cas 126833-17-8): A biophysical prospect07/20/2019


